Hajime Senjo to Treatment Outcome
This is a "connection" page, showing publications Hajime Senjo has written about Treatment Outcome.
Connection Strength
0.081
-
Serum level of soluble interleukin-2 receptor is positively correlated with metabolic tumor volume on 18 F-FDG PET/CT in newly diagnosed patients with diffuse large B-cell lymphoma. Cancer Med. 2019 03; 8(3):953-962.
Score: 0.048
-
Event-free survival at 36 months is a suitable endpoint for diffuse large B-cell lymphoma patients treated with immunochemotherapy: real-world evidence from the North Japan Hematology Study Group. Haematologica. 2024 11 01; 109(11):3631-3640.
Score: 0.018
-
Dynamic change in peripheral blood WT1 mRNA levels within three cycles of azacitidine predict treatment response in patients with high-risk myelodysplastic syndromes. Ann Hematol. 2022 Jun; 101(6):1239-1250.
Score: 0.015